Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 576 to 600 of 1861

TitleReference numberPublishedLast updated
Enzalutamide for treating hormone-sensitive metastatic prostate cancerTA712
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA377
Epcoritamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatmentsTA954
Epidermal radiotherapy using rhenium-188 paste for non-melanoma skin cancerIPG784
Epiduroscopic lumbar discectomy through the sacral hiatus for sciaticaIPG570
Epilepsies in children, young people and adultsNG217
Epiretinal brachytherapy for wet age-related macular degenerationIPG415
Episcissors-60 for mediolateral episiotomyMTG47
Epithelial radiofrequency ablation for Barrett's oesophagusIPG344
Eptinezumab for preventing migraineTA871
Erenumab for preventing migraineTA682
Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimenTA515
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapyTA374
Erlotinib for the first-line treatment of locally advanced or metastatic EGFR-TK mutation-positive non-small-cell lung cancerTA258
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancerTA227
Ertugliflozin as monotherapy or with metformin for treating type 2 diabetesTA572
Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetesTA583
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapyTA323
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)TA899
Esketamine nasal spray for treatment-resistant depressionTA854
Etanercept and efalizumab for the treatment of adults with psoriasisTA103
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritisTA199
Etelcalcetide for treating secondary hyperparathyroidismTA448
Etrasimod for treating moderately to severely active ulcerative colitis in people aged 16 and overTA956

Results per page

  1. 10
  2. 25
  3. 50
  4. All